Mycobacterium tuberculosis remains a significant global health concern largely due to its ability to persist for extended periods within the granuloma of the host. While residing within the granuloma, the tubercle bacilli are likely to be exposed to stress that can result in formation of aberrant proteins with altered structures. Bacteria encode stress responsive determinants such as proteases and chaperones to deal with misfolded or unfolded proteins. pepD encodes an HtrA-like serine protease and is thought to process proteins altered following exposure of M. tuberculosis to extra-cytoplasmic stress. PepD functions both as a protease and chaperone in vitro, and is required for aspects of M. tuberculosis virulence in vivo. pepD is directly regulated by the stress-responsive two-component signal transduction system MprAB and indirectly by extracytoplasmic function (ECF) sigma factor SigE. Loss of PepD also impacts expression of other stress-responsive determinants in M. tuberculosis. To further understand the role of PepD in stress adaptation by M. tuberculosis, a proteomics approach was taken to identify binding proteins and possible substrates of this protein. Using subcellular fractionation, the cellular localization of wild-type and PepD variants was determined. Purified fractions as well as whole cell lysates from Mycobacterium smegmatis or M. tuberculosis strains expressing a catalytically compromised PepD variant were immunoprecipitated for PepD and subjected to LC-MS/MS analyses. Using this strategy, the 35-kDa antigen encoding a homolog of the PspA phage shock protein was identified as a predominant binding partner and substrate of PepD. We postulate that proteolytic cleavage of the 35-kDa antigen by PepD helps maintain cell wall homeostasis in Mycobacterium and regulates specific stress response pathways during periods of extracytoplasmic stress.
Mycobacterium tuberculosis remains a significant global health concern largely due to its ability to persist for extended periods within the granuloma of the host. While residing within the granuloma, the tubercle bacilli are likely to be exposed to stress that can result in formation of aberrant proteins with altered structures. Bacteria encode stress responsive determinants such as proteases and chaperones to deal with misfolded or unfolded proteins. pepD encodes an HtrA-like serine protease and is thought to process proteins altered following exposure of M. tuberculosis to extra-cytoplasmic stress. PepD functions both as a protease and chaperone in vitro, and is required for aspects of M. tuberculosis virulence in vivo. pepD is directly regulated by the stress-responsive two-component signal transduction system MprAB and indirectly by extracytoplasmic function (ECF) sigma factor SigE. Loss of PepD also impacts expression of other stress-responsive determinants in M. tuberculosis. To further understand the role of PepD in stress adaptation by M. tuberculosis, a proteomics approach was taken to identify binding proteins and possible substrates of this protein. Using subcellular fractionation, the cellular localization of wild-type and PepD variants was determined. Purified fractions as well as whole cell lysates from Mycobacterium smegmatis or M. tuberculosis strains expressing a catalytically compromised PepD variant were immunoprecipitated for PepD and subjected to LC-MS/MS analyses. Using this strategy, the 35-kDa antigen encoding a homolog of the PspA phage shock protein was identified as a predominant binding partner and substrate of PepD. We postulate that proteolytic cleavage of the 35-kDa antigen by PepD helps maintain cell wall homeostasis in Mycobacterium and regulates specific stress response pathways during periods of extracytoplasmic stress.
Tuberculosis remains a significant global health concern with estimates indicating
that one-third of the world's population is currently latently infected by the
causative organism, Mycobacterium tuberculosis
[1]. The genetic
programs required by M. tuberculosis for establishment,
maintenance, and/or reactivation from persistent infection within the host remain
poorly defined, but are thought to include stress-adaptation systems such as
extracytoplasmic function (ECF) sigma factors and two-component signal transduction
systems. mprAB is one of 11 complete two-component system encoded
within the genome of M. tuberculosis
[2]. This system
directly regulates expression of numerous stress-responsive determinants in
M. tuberculosis including ECF sigma factors
sigE and sigB, alpha crystallin gene
acr2, and serine protease pepD
[3], [4], [5], [6]. MprAB is required
for in vivo growth of the tubercle bacillus during persistent
stages of infection [7], and its expression is up-regulated within an artificial
granuloma model system [8] and under various conditions in vitro
likely to be experienced by M. tuberculosis during residence within
the granuloma [4],
[6], [9].PepD is a member of the HtrA-like protease family and is encoded immediately
downstream of mprAB in all Mycobacterium species
examined to date. HtrA-like proteases represent a well-conserved family of enzymes,
and are responsible for degrading or refolding protein substrates following exposure
to stress [10].
In vitro, PepD functions as both a protease and a chaperone
[11]. In Mycobacterium smegmatis, loss of
pepD enhances sensitivity of this bacterium to various cell
wall-targeting antibiotics and detergents [12]. In contrast,
pepD mutants of M. tuberculosis display a
pleiotrophic phenotype; they are unaltered in survival following exposure to SDS
[12], and they
exhibit similar in vivo growth kinetics within tissues of infected
mice compared to their wild-type counterparts [11]. However, these
mutants do display an increased time to death in mice and are associated with
reduced tissue pathology [11]. These phenotypes, coupled with the observation that
pepD deletion results in upregulation of numerous
stress-responsive determinants in M. tuberculosis under
physiological conditions including sigE
[12], underscores
the complex regulation and multifaceted activity of this protein.PepD is 464 amino acids and contains an N-terminal cytoplasmic domain (amino acids
1–101), a small transmembrane domain (amino acids 102–124), a catalytic
protease domain (amino acids 166–364), and a C-terminal PDZ domain (amino
acids 368–446). While most HtrA-like proteins possess either one or two PDZ
domains [10] many of
these proteins lack an N-terminal cytoplasmic domain. Previous studies have
demonstrated that PepD processes artificial substrates including β-casein [11],
[12] and pig
heart citrate synthase [11]; however, natural substrates of PepD have yet to be
identified. Proteolysis of β-casein requires the PDZ domain [12] and the
catalytic serine at position 317 [11], [12]. The PDZ domain
is also critical for regulating the activities of other HtrA proteases including
DegS in Escherichia coli, one of the best characterized family
members [13],
[14],
[15].
Additionally (or alternatively), interactions with PepD may localize to the
N-terminal 101 amino acids, a region predicted to be cytoplasmic. To further
understand the role of PepD in adaptation to stress, a proteomics approach was taken
to identify proteins involved in the PepD-mediated stress response. Here we identify
the 35-kDa antigen of M. tuberculosis (Rv2744c) as a target of the
PepD protease.
Methods
Bacterial strains, media, and growth conditions
Strains and plasmids used in the study are described in Table S1.
Escherichia coli Top 10 (Invitrogen, Carlsbad, CA), XL
10-Gold (Agilent Technologies, Santa Clara, CA), and DH5α were used for
cloning procedures. BL21(DE3)/pLysS (Novagen, La Jolla, CA) was used to express
and purify recombinant proteins in E. coli. All E.
coli strains were grown with aeration at 37°C in Luria-Bertani
(LB) broth or on LB agar (Thermo Fisher Scientific, Waltham, MA). When required,
medium was supplemented with 25 µg/ml chloramphenicol (Sigma, St. Louis,
MO), 150 µg/ml hygromycin B (AG Scientific, San Diego, CA), 100
µg/ml ampicillin (Thermo Fisher Scientific, Waltham, MA), and/or 50
µg/ml kanamycin sulfate (Thermo Fisher Scientific, Waltham, MA).
Mycobacterium strains used in this study are all
derivatives of Mycobacterium tuberculosis H37Rv (ATCC 27294) or
Mycobacterium smegmatis mc2155 (ATCC 700084).
Mycobacteria were grown with aeration at 37°C in Middlebrook 7H9 broth or
7H10agar medium (Difco, Franklin Lakes, NJ) supplemented with 0.5%
glycerol, 10% ADC or OADC (Difco, Franklin Lakes, NJ), and 0.05%
Tween 80. For protein production, Mycobacteria were also grown in glycerol
alanine salts (GAS) [16]. When required, Mycobacteria medium was supplemented
with 25 µg/ml kanamycin sulfate (Thermo Fisher Scientific, Waltham, MA),
50 µg/ml hygromycin B (AG Scientific, San Diego, CA), and/or 50
µg/ml cyclohexamide (Thermo Fisher Scientific, Waltham, MA).
DNA manipulations
Restriction enzyme digests, cloning, subcloning, and DNA electrophoresis were
done according to standard techniques [17]. Oligonucleotides and
primers were synthesized by Eurofins MWG Operon (Huntsville, AL) and are listed
in Table
S2. PCR was performed using High Fidelity Platinum PCR Supermix or
Taq polymerase (Invitrogen, Carlsbad, CA). All amplified products were cloned
into pCR2.1-TOPO (Invitrogen, Carlsbad, CA) and sequenced to confirm the absence
of mutations. Ligations were performed using the Quick Ligation Kit (New England
Biolabs, Beverly, MA) or T4 DNA ligase (Invitrogen, Carlsbad, CA). When
necessary, plasmid DNA was treated with Antarctic phosphatase (New England
Biolabs, Beverly, MA) to prevent religation of vector ends. Electroporation or
transformation of plasmid DNA into E. coli or
Mycobacterium was conducted as previously described [18]. Plasmid
DNA was prepared using the QIAprep Spin Miniprep Kit (Qiagen, Venlo, The
Netherlands) as recommended by the manufacturer. Genomic DNA was isolated from
M. tuberculosis as described [18]. DNA fragments were
purified using either the QIAquick Gel Extraction Kit or QIAquick PCR
Purification Kit (Qiagen, Venlo, The Netherlands). The
pepDS317A mutant allele was generated using the QuickChange XL
site-directed mutagenesis kit (Stratagene, La Jolla, CA). DNA sequencing was
performed with an ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction
Kit (Applied Biosystems, Carlsbad, CA) using an automated long capillary method
(ABI PRISM 3100 Genetic Analyzer, Applied Biosystems, Carlsbad, CA).
Construction of epitope-tagged fusion proteins
Construction of pTZ758 encoding PepDΔTM was described previously [12].
Mycobacterium proteins containing N-terminal 3x-FLAG and C-terminal 6x-His
epitope tags were generated using a three step cloning strategy. First,
complementary oligonucleotides carrying the coding sequence for 3xFLAG were
hybridized and ligated into cloning vector pCR2.1-TOPO. Second, the 3x-Flag
coding sequence was amplified from pTZ806 using primers FLAGfwd-NdeI and
FLAGrev-NdeI and subcloned into pET-24b (Novagen, La Jolla, CA) upstream of and
in frame with the C-terminal 6x-His epitope tag. The resulting construct,
pTZ842, served as the base plasmid for introduction of all subsequent M.
tuberculosis sequences. Finally, to express epitope-tagged proteins
in Mycobacterium, coding sequences were PCR amplified from
pTZ842 variants using primers pET24fwd-PstI and pET24rev-HindIII and
directionally subcloned into pSE100 [19]. This vector is an E.
coli-Mycobacterium shuttle plasmid that contains the highly
expressed myc promoter element upstream of the Tet operator
site.
Production and purification of recombinant proteins in E.
coli
E. coliBL21(DE3)/pLysS strains containing over-expression
constructs were grown overnight on selective LB agar medium, suspended in LB
broth containing kanamycin and chloramphenicol, and grown to mid-exponential
phase. Protein over-production was induced by the addition of 0.1 mM IPTG
(Isopropyl-β-D-thiogalactopyranoside; Invitrogen, Carlsbad, CA) for 3 hours
at 30°C. Induced cells were suspended in lysis buffer (20 mM Tris [pH
7.9], 500 mM NaCl, 5 mM imidazol, and 6 µg of DNAse/ml), passed
3× through a French press, and centrifuged at 25,000×
g for 30 min. Cellular supernatants were passed over a
nickel nitrilotriacetic acid-agarose column (Qiagen, Valencia, CA) and collected
fractions pooled. Some proteins were further purified by size exclusion and
anion exchange chromatography essentially as described [12]. Purified protein fractions
were pooled and dialyzed overnight against dialysis buffer (20 mM Tris [pH
7.9], 150 mM NaCl, 20% glycerol). Purified proteins were stored at
−80°C.
Expression, fractionation, and localization of endogenous or epitope-tagged
proteins in Mycobacterium
M. smegmatis or M. tuberculosis wild-type or
recombinant derivatives containing pSE100-based expression constructs were grown
in GAS medium to stationary phase (OD600>1.5). Culture filtrate
proteins (CFP) were collected by passing spent broth medium through 0.25
µm low-protein binding filters (Corning, Lowell, MA) and concentrating the
eluent using Amicon Ultracell-15 (10,000 molecular weight cutoff) spin columns.
Non-secreted proteins were obtained by suspending the bacterial pellet in
phosphate-buffered saline (PBS) containing protease inhibitors and mechanically
disrupting the bacteria by bead beating. A low speed spin (11,000×
g) was used to separate cell debris from the whole cell
lysate. The resulting supernatant was clarified by passage through a 0.25
µm low-protein binding syringe filter (Corning, Lowell, MA). For all
preparations generated in M. tuberculosis, protein-containing
samples were checked for sterility using viability assays prior to removing from
the BSL3 laboratory. Whole cell lysates were further separated into cell wall,
cell membrane, and cytosolic fractions by differential ultracentrifugation as
described previously [20]. Protein concentrations were determined using the BCA
Protein Assay (Pierce, Rockford, IL). Protein lysates were added to 2×
SDS-PAGE loading dye, boiled for 5 min, separated on 12% SDS-PAGE gels,
and transferred onto Immobilon-P membranes (Millipore, Billerica, MA). Membranes
were blocked in TTBS (20 mM Tris-HCl [pH 7.5], 500 mM NaCl,
0.5% Tween 20) containing 5% skim milk for at least 1 hour and
probed with the antisera diluted in TTBS overnight at 4°C. Anitsera included
rabbit polyclonal anti-PepD (1∶10,000 dilution) [12], rabbit polyclonal anti-MprA
(1∶10,000 dilution; Covance, Princeton, NJ), rabbit polyclonal anti-MprB
(1∶10,000 dilution; Covance, Princeton, NJ), rabbit polyclonal
anti-Mycobacterium tuberculosis strain H37Rv LAM
([1∶10,000 dilution; NR-18321] from the TB Vaccine Testing and
Research Materials Contract (BEI Resources, Manassas, VA)), and murine
monoclonal anti-Mycobacterium smegmatis LAM
([1∶10,000 dilution; NR-13798] from the TB Vaccine Testing and
Research Materials Contract (BEI Resources, Manassas, VA)). Membranes were
washed in TTBS and incubated for 30 min at room temperature with goat
anti-rabbit (1∶5,000 dilution) or goat anti-mouse (1∶5,000)
secondary antibody conjugated to horseradish peroxidase (Pierce, Rockford, IL).
Blots were developed using the SuperSignal West Femto Chemiluminescent Substrate
kit (Pierce, Rockford, IL) and visualized on CL-XPosure X-ray film (Thermo
Scientific, Rockford, IL).
Immunoprecipitation of 3x-Flag-tagged proteins in
Mycobacterium and identification of protein-protein
interactions
Mycobacterium protein factions were collected from experimental
or control strains expressing 3x-FLAG-tagged proteins as previously described. A
50 µl slurry of washed Anti-FLAG M2 agarose beads (Sigma, St. Louis, MO)
was added to each sample and rocked at 4°C for 2 h. Beads were washed twice
with PBS/0.1% Triton X-100 (Sigma, St. Louis, MO), and proteins eluted
using 90 µM FLAG peptide (Sigma, St. Louis, MO) suspended in
PBS/0.1% Triton X-100. Immunoprecipitated proteins were separated on
12% SDS-PAGE gels and were stained with GelCode Blue (Thermo, Waltham,
MA) or by silver staining. Alternatively, proteins were separated and visualized
using the Agilent 2100 Bioanalyzer and High Sensitivity Protein 250 Kit (Agilent
Technology, Santa Clara, CA). For analysis by LC-MS/MS, protein samples were
briefly run into the resolving gel to separate out the faster-migrating FLAG
peptide. Remaining protein was excised from the gel, divided into two parts, and
subsequently processed as two individual samples. The gel in each sample was
diced into approximately 1 mm3 squares and destained using iterations
of 25 mM ammonium bicarbonate (ABC)/50% acetonitrile (ACN) with agitationat 4°C. Gel pieces were then dehydrated with 100% ACN with subsequent
rehydration and overnight incubation with 150 ng mass spectrometry grade Trypsin
Gold (Promega, Madison, WI) in 50 mM ABC/10% ACN at 37°C with gentle
rocking. Peptides were extracted using POROS 20 R2 reverse phase resin (Applied
Biosystems, Foster City, CA) in 2.5% formic acid (FA)/0.1%
trifluoroacetic acid (TFA) with agitation overnight at 4°C. Peptides were
desalted using C18 ZipTip columns (Millipore, Billerica, MA) by washing with
0.1% TFA and eluting with 95% ACN/0.005% TFA followed by
70% ACN/0.03% TFA. Eluates from the same original resolving gel
lane were combined and dried by spin vacuum evaporation. Peptides were
resuspended in 5% ACN/0.1% FA, and loaded onto an ESI-LTQ XL mass
spectrometer (Thermo, Waltham, MA) for identification by LC-MS/MS of the 6 most
abundant peptides per precursor scan. Peptide identification was carried out
using the search algorithm SEQUEST [21] by searching the M. smegmatis or
M. tuberculosis protein database. Data was analyzed using
the in-house software Visualize (http://proteomics.mcw.edu/visualize).
Bacterial two-hybrid and β-galactosidase analysis
Specific protein-protein interactions were detected using the bacterial
two-hybrid system, BACTH (Euromedex, Souffelweyersheim, France), per the
manufacturer's directions. Briefly, the Rv2744c coding
sequence was amplified from M. tuberculosis H37Rv genomic DNA
and subcloned into T25- and/or T18-fusion vectors supplied by the manufacturer.
Vectors constructed for this analysis are listed in Table S1.
Plasmids were co-transformed into the E. coli BTH101 reporter
strain. Resulting transformants were then plated on MacConkey/maltoseagar
medium, incubated at 30°C for 48–72 hours, and screened for the
presence of a red colony phenotype indicative of protein-protein interactions.
The extent of protein-protein interactions were quantified using
β-galactosidase assays essentially as described [22].
Protease activity assays
Proteolytic activity of PepDΔTM against potential substrates was determined
using previously established procedures [12]. Briefly, increasing amounts
of purified PepDΔTM were incubated with fixed amounts of the substrate in 50
mM potassium phosphate buffer (pH 7.5) at 37°C. Reaction mixtures were then
separated using SDS-PAGE and stained with Coomassie blue for visualization.
In vitro sensitivity assays
Sensitivity of M. smegmatis derivatives to antibiotic stress was
measured using disc diffusion assays. Petri dishes were poured using 25 ml 7H9
bottom agar (1.2% agar) per dish. 100 µl aliquots of M.
smegmatis cultures were added to 3.5 ml of 0.6% 7H9 top agar
tempered to 55°C, poured onto bottom agar plates, and allowed to solidify.
Sterile filter discs (6 mm) were added on top of the media and impregnated with
5 µl of 5 mg/ml vancomycin (Sigma, St. Louis, MO), 50 mg/ml cycloserine
(Sigma, St. Louis, MO), 50 mg/ml isoniazid (Sigma, St. Louis, MO), or 10
µl of 50 mg/ml cefuroxime (Sigma, St. Louis, MO). Plates were incubated at
37°C and zones of inhibition were measured after 2 days. Stock and working
antibiotic concentrations were prepared in sterile water.
Statistical analysis
All statistical analyses were conducted using a Student's t-test. Values
were determined to be statistically significant at
P<0.05.
Results
Localization of PepD
PepD contains a single transmembrane domain and is predicted to localize to the
plasma membrane. However, recent reports from us and others have indicated that
PepD may also undergo autocatalysis and be secreted into the CFP [11],
[12], [23]. To
investigate PepD localization, subcellular compartments of M.
tuberculosis ΔpepD expressing wild-type,
mutant, or epitope-tagged forms of pepD (Table S1)
were collected (Figure 1A)
and subjected to immunoblot analyses [20]. M.
tuberculosis ΔpepD expressing wild-type
pepD from an integrated vector was observed as a ∼55
kDa protein in multiple fractions including the cytosol, cell membrane, and cell
wall (Figure 1B). Additional
lower molecular mass immunoreactive proteins were also observed in these
fractions, likely a result of PepD autocatalysis during fractionation of the
whole cell lysate as these peptides were less abundant in M.
tuberculosis ΔpepD expressing the
pepDS317A allele (Figure 1C). A processed form of PepD with a
reduced molecular mass of ∼35 kDa was also observed in the CFP (Figure 1B), similar to that
previously reported [23]. Observed proteins were PepD-specific, as
immunoreactive proteins were not detected in fractions prepared from an
M. tuberculosis ΔpepD strain (data not
shown, and [12]). Control proteins including response regulator MprA,
sensor kinase MprB, and glycolipid lipoarabinomannam localized to the expected
compartments, validating the differential separation procedure (Figure 1B).
Figure 1
Localization of PepD.
A) Schematic depicting the differential centrifugation protocol used to
fractionate PepD in M. tuberculosis. B) Western blot
showing the localization pattern of wild-type PepD in various
subcellular compartments. MprA is used as a cytosolic marker, MprB is a
cell membrane marker, and LAM is a cell envelope marker. C) Western blot
showing the localization of the S317A mutant of PepD. D) Western blot
demonstrating the localization of an overexpressed 3xFLAG-PepD-6xHis
variant. Lanes: CFP, culture filtrate protein; CW, cell wall; CM, cell
membrane; Cyt, cytosol.
Localization of PepD.
A) Schematic depicting the differential centrifugation protocol used to
fractionate PepD in M. tuberculosis. B) Western blot
showing the localization pattern of wild-type PepD in various
subcellular compartments. MprA is used as a cytosolic marker, MprB is a
cell membrane marker, and LAM is a cell envelope marker. C) Western blot
showing the localization of the S317A mutant of PepD. D) Western blot
demonstrating the localization of an overexpressed 3xFLAG-PepD-6xHis
variant. Lanes: CFP, culture filtrate protein; CW, cell wall; CM, cell
membrane; Cyt, cytosol.It has been reported that the 35-kDa form of PepD observed in the CFP results
from a(n) autoproteolytic cleavage event(s) in the extracytoplasmic portion of
the protein and is dependent on catalytic residue Ser-317 [11]. To determine
whether this cleavage event was required for translocation of PepD from the cell
membrane/cell wall to the CFP, analogous subcellular fractionation studies were
carried out using M. tuberculosis ΔpepD
expressing pepDS317A which encodes a PepD variant exhibiting
10% of the activity of wild-type PepD [11], [12]. In contrast
to wild-type PepD, full length PepDS317A localized predominantly to the cell
wall, although protein was also detected in the cell membrane and cytoplasm.
Importantly, substantially less of the 35-kDa form of PepD was observed in the
CFP, indicating that amino acid residue S317 is required for efficient
processing of full length PepD to the 35-kDa form (Figure 1C). Finally, to confirm that
over-production and/or addition of N- or C-terminal epitope tags does not alter
the localization of PepD, fractionation studies were repeated using
Mycobacterium ΔpepD strains carrying
pTZ1049 (a pSE100 derivative constitutively expressing
3x-FLAG-PepDWT-6xHis). Epitope-tagged PepD over-produced in
M. tuberculosis (Figure 1D) and M. smegmatis
(Figure
S1) fractionated similarly to wild-type PepD. Taken together, these
data indicate that PepD traffics from the cytoplasm through the cell membrane to
the cell wall where it is autoprocessed and eventually shed into the CFP as a
35-kDa form.
Identification of PepDS317A interacting proteins
To identify potential interactants and/or substrates of PepD,
co-immunoprecipitation (co-IP) studies were conducted with M.
smegmatis ΔpepD carrying pSE100 or M.
smegmatis ΔpepD expressing PepDS317A
containing a 3xFLAG epitope on the amino terminus and a 6xHis sequence on the
carboxyl terminus (pTZ1066). The PepDS317A variant was chosen to minimize
autocatalysis and maximize protein-protein interactions with potential partners.
In addition, both whole cell lysates and cell wall fractions were collected and
incubated with anti-FLAG antibody conjugated to agarose beads to capture
proteins from the various subcellular compartments that may interact with PepD.
To determine the efficiency and specificity of IP, aliquots from whole cell
lysates corresponding to the load (L), unbound (U), wash (W1 and W2), and elute
(E) fractions were first analyzed and quantified for PepD by immunoblot using a
mouse anti-FLAG monoclonal antibody. An immunoreactive protein migrating at the
expected molecular mass was detected in samples prepared from M.
smegmatis containing pTZ1066 (Figure 2A) but not pSE100 (data not shown).
Quantification by densitometry indicated that ∼20% of the total
epitope tagged PepDS317A present was pulled down (Figure 2A). Importantly, little PepDS317A was
lost during washing and PepDS317A was enriched in the IP eluate (Figure 2A). When analyzed on a
12% SDS-PAGE gel stained with silver, a number of co-immunoprecipitating
peptides were also apparent in addition to PepDS317A (Figure 2B). Analysis of IP eluants using an
Agilent Bioanalyzer indicated that PepD interacted with multiple proteins
possessing a range of molecular masses and that were present at various levels
of abundance (Figure 2C).
Taken together, these results demonstrate that PepDS317A interacts with numerous
proteins in M. smegmatis.
Figure 2
Immunoprecipitation of rPepD.
Immunoprecipitation with anti-Flag antibody of M.
smegmatis cultures expressing a vector containing
3xFlag-PepDS317A-6xHis. Immunoprecipitations were visualized using
Western blot (A) or silver stain (B). Lanes: La, ladder; L, load; U,
unbound; W1, first wash; W2, second wash; and E, elute. The arrow
indicates the predicted location of 3xFlag-PepDS317A-6xHis. C)
Electrophoretogram depicting the molecular masses and relative abundance
of proteins co-immunoprecipitated with 3xFlag-PepDS317A-6xHis.
Immunoprecipitation of rPepD.
Immunoprecipitation with anti-Flag antibody of M.
smegmatis cultures expressing a vector containing
3xFlag-PepDS317A-6xHis. Immunoprecipitations were visualized using
Western blot (A) or silver stain (B). Lanes: La, ladder; L, load; U,
unbound; W1, first wash; W2, second wash; and E, elute. The arrow
indicates the predicted location of 3xFlag-PepDS317A-6xHis. C)
Electrophoretogram depicting the molecular masses and relative abundance
of proteins co-immunoprecipitated with 3xFlag-PepDS317A-6xHis.To determine the identity of proteins co-immunoprecipitating with epitope-tagged
PepDS317A, total cell or cell wall IP eluents from M. smegmatis
ΔpepD containing pSE100 or pTZ1066 were subjected to
LC-MS/MS analysis. Proteins were designated putative binding partners if they
met the following criteria: (i) possessed a minimum peptide probability cut-off
of 0.85, (ii) were represented by two or more unique peptides, and (iii) were
present in the experimental pTZ1066 but not the control pSE100 dataset. 197
proteins were identified in the total cell lysate that co-immunoprecipitated
with PepDS317A (Table S3), while 126 proteins from the cell wall fraction
co-immunoprecipitated with this derivative (Table S4).
56 of the identified proteins were conserved in both M.
smegmatis data sets (Table S5). These proteins fell into multiple
functional categories including protein synthesis, energy metabolism, and
protein fate (Table S5). The highest scoring protein based on percent coverage in
both data sets was MSMEG_2695 (Tables S3 and S4). This
protein is 91% similar and 85% identical to M.
tuberculosis Rv2744c, and is also known as the 35-kDa antigen.
Rv2744c is homologous to PspA from E. coli, a protein involved
in the phage shock response in Gram-negative bacteria, and in homeostasis of the
cell membrane including maintenance of proton motive force [24]. To determine whether the
identified interactions were specific to only M. smegmatis,
co-IP and LC-MS/MS analyses were repeated on total cell lysates isolated from
M. tuberculosis ΔpepD carrying pSE100
or pTZ1066. A total of 200 proteins co-immunoprecipitated exclusively with
PepDS317A in these samples (Table S6). Similar to M.
smegmatis, the top scoring protein based on protein coverage was
the 35-kDa antigen Rv2744c (Table S6). A variety of other proteins from
multiple functional families including intermediary metabolism and respiration,
lipid metabolism, and cell wall processes were also identified. Twenty of the
identified M. tuberculosis proteins were also present in the
list of 56 proteins conserved in both M. smegmatis datasets
(Table
S5). Based on these results, we conclude that PepD interacts with
numerous proteins in both M. smegmatis and M.
tuberculosis, including the 35-kDa antigen.
Identification of PepD substrates
To determine whether any of the M. tuberculosis proteins
associated with PepD are potential substrates, IP eluants were incubated with
active PepDΔTM [12], subjected to trypsin digestion and analyzed using
LC-MS/MS. Peptides resulting solely from tryptic cleavage were removed from the
dataset, leaving a collection of 13 unique proteins with semi-tryptic cleavage
sites (Table
S7). PepD was the highest scoring protein with 33 unique non-tryptic
peptides (Table
S8). Several of the identified cleavage sites match those previously
reported for PepD which undergoes autocatalysis [11], validating the
utility of this assay. Proteins not meeting the minimum peptide number and
probability requirement described previously were further removed from the list,
resulting in 4 candidate targets each consisting of a single semi-tryptic
peptide fragment (Table
1). Based on protein probability, Rv2744c remained the top scoring
protein (Table 1). Other
proteins identified included Rv1310 (AtpD), Rv0350 (DnaK), and Rv1266c (PknH).
Thus, PepD alone or as part of a larger protein complex interacts with and
potentially cleaves several proteins in M. tuberculosis,
including the 35-kDa antigen.
Table 1
Putative PepD substrates with semi-tryptic ends.
Rv No.a
Genea
Protein Probabilityb
Peptide identifiedc
Gene Producta
Rv2744c
1.00
F.AAQLVTAEQSVEDLK
35-kDa protein
Rv1310
atpD
0.96
V.TGPVVDVEFPR
ATP synthase subunit beta
Rv1266c
pknH
0.89
A.GAAAVVLVLVLGAIGIWIAIR
Serine/threonine protein kinase
Rv0350
dnaK
0.89
P.DEVVAVGAALQAGVLK
Chaperone protein
Protein information based on Pasteur Institutes' Tuberculist
website (http://genolist.pasteur.fr/Tuberculist).
Protein probability assigned by spectra following LC-MS/MS.
Semi-tryptic peptide identification with annotated cleavage site.
Protein information based on Pasteur Institutes' Tuberculist
website (http://genolist.pasteur.fr/Tuberculist).Protein probability assigned by spectra following LC-MS/MS.Semi-tryptic peptide identification with annotated cleavage site.
The 35-kDa antigen is a binding partner and potential substrate of
PepD
The 35-kDa antigen was previously identified to be upregulated upon exposure to
vancomycin, implicating a role for this determinant in resistance to cell
envelope stress [25]. To confirm that this protein interacted with PepD,
reverse co-IP's were carried out in M. smegmatis
ΔpepD strains carrying pSE100 or pTZ1175 (pSE100
expressing 3xFLAG-Rv2744c-6xHis). M. smegmatis
ΔpepD strains utilized in this assay also expressed
M. tuberculosis pepD or pepDS317A [12], as the
polyclonal antibody to M. tuberculosis PepD does not recognize
the homologue in M. smegmatis. SDS-PAGE analysis of anti-FLAG
IP eluants indicated the presence of proteins migrating at molecular masses
expected for both epitope-tagged Rv2744c and PepD (Figure 3A). Western blot analysis further
confirmed the presence of these proteins in IP eluants from strains expressing
Rv2744c (Figure 3B), but not
the vector only control (Figure
3C). Interestingly, a protein running at the expected molecular mass
of endogenous MSMEG_2695 was also observed in the M. smegmatis
strain expressing M. tuberculosis pepDS317A but not in the
strain expressing wild-type M. tuberculosis pepD (Figure 3A and Figure 2B). LC-MS/MS analysis
of this protein confirmed it as MSMEG_2695 (data not shown).
Figure 3
Immunoprecipitation of rRv2744c.
(A) Immunoprecipitation with anti-Flag antibody of M.
smegmatis ΔpepD strains complemented
with either M. tuberculosis pepD
wt (left
panel) or pepD317A (right panel) and expressing a
vector containing 3xFlag-Rv2744c-6xHis. Immunoprecipitations were
visualized by silver stain. Lanes: L, load; U, unbound; W1, first wash;
W2, second wash; and E, elute. The arrow indicates the predicted
location of 3xFlag-Rv2744c-6xHis, the asterisk (*) indicates the
predicted location of PepD, and the hatch mark indicates the location of
MSMEG_2695. (B) Western blot demonstrating the immunoprecipitation of
PepD with 3xFlag-Rv2744c-6xHis using antibodies to either the Flag
epitope or PepD. (C) Western blot demonstrating the specificity of
anti-FLAG immunoprecipitation from a M. smegmatis
ΔpepD strain carrying the pSE100 expression
vector alone. (D) Western blot showing the localization of
3xFlag-Rv2744c-6xHis in various subcellular compartments in M.
smegmatis. Lanes: CFP, culture filtrate protein; CW, cell
wall; CM, cell membrane; Cyt, cytosol.
Immunoprecipitation of rRv2744c.
(A) Immunoprecipitation with anti-Flag antibody of M.
smegmatis ΔpepD strains complemented
with either M. tuberculosis pepD
wt (left
panel) or pepD317A (right panel) and expressing a
vector containing 3xFlag-Rv2744c-6xHis. Immunoprecipitations were
visualized by silver stain. Lanes: L, load; U, unbound; W1, first wash;
W2, second wash; and E, elute. The arrow indicates the predicted
location of 3xFlag-Rv2744c-6xHis, the asterisk (*) indicates the
predicted location of PepD, and the hatch mark indicates the location of
MSMEG_2695. (B) Western blot demonstrating the immunoprecipitation of
PepD with 3xFlag-Rv2744c-6xHis using antibodies to either the Flag
epitope or PepD. (C) Western blot demonstrating the specificity of
anti-FLAG immunoprecipitation from a M. smegmatis
ΔpepD strain carrying the pSE100 expression
vector alone. (D) Western blot showing the localization of
3xFlag-Rv2744c-6xHis in various subcellular compartments in M.
smegmatis. Lanes: CFP, culture filtrate protein; CW, cell
wall; CM, cell membrane; Cyt, cytosol.To verify that the 35-kDa antigen localized to the same compartment(s) as PepD,
fractionation and Western blot assays were carried out on M.
smegmatis strains expressing epitope-tagged Rv2744c. The 35-kDa
antigen localized to the cell wall and cell membrane compartments (Figure 3D), consistent with
the localization pattern of PepD previously observed. Also, the presence of a
lower molecular weight protein immunoreactive with the anti-FLAG monoclonal
antibody was also present in the strain expressing wild-type M.
tuberculosis pepD but not pepDS317A (Figure 3D), indicating that
PepD potentially cleaves the 35-kDa antigen. While the size of this lower
molecular weight band is not consistent with the cleavage site detected by
LC-MS/MS (Table 1), the
two experiments utilize different detection readouts and cannot be directly
compared. Additionally, peptides from the C-terminal region of the 35-kDa
antigen were not detected by LC-MS/MS for any of the
MycobacteriumPepD immunoprecipitation experiments
(Supplemental Tables S3 and S4), the region of Rv2744c predicted to be
cleaved by PepD based on results from Western blot studies (Figure 3D). Regardless, this data confirms
the interaction between the 35-kDa antigen and PepD, and further supports the
contention that this protein is a substrate of PepD.
Rv2744c over-production restores resistance to ΔpepD
mutants of M. smegmatis against specific cell wall-damaging
antibiotics
Previous studies have demonstrated that ΔpepD mutant strains
of M. smegmatis exhibit increased sensitivity to cell wall
antibiotics including cycloserine and cefuroxime [12]. To determine whether
Rv2744c may function to regulate cell wall homeostasis in
Mycobacterium
[24],
in vitro antibiotic susceptibility assays were carried out
with ΔpepDM. smegmatis mutant strains expressing
Rv2744c. ΔpepD strains harbouring
pSE100 were significantly more sensitive to vancomycin, cycloserine, and
cefuroxime compared to their wild-type counterparts containing pSE100 (Table 2). In contrast,
expression of Rv2744c from pSE100 in M.
smegmatis ΔpepD restored resistance to these
antibiotics to near wild-type levels (Table 2). The observed sensitivity of
M. smegmatis ΔpepD mutants but not
ΔpepD mutants expressing Rv2744c was
specific to antibiotics targeting the peptidoglycan, as no differences were
observed between M. smegmatis strains following exposure to
isoniazid, an antibiotic that inhibits fatty acid synthase and synthesis of cell
wall mycolic acids (Table
2). Overall, these data argue that over-expression of
Rv2744c increases resistance of M.
smegmatis to peptidoglycan-disrupting antibiotics, possibly helping
to maintain cell wall homeostasis.
Table 2
Susceptibility of M. smegmatis strains to cell-wall
targeting antibioticsa.
Strain
Vancomycinb
Cycloserinec
Cefuroximed
INHe
mc2155/pSE100
13.7±0.3
18.5±0.3
6±0
46.7±0.3
ΔpepD/pSE100
16±0*
20.5±0.3*
12.7±0.9*
46.7±0.3
ΔpepD/pTZ1175
14.3±0.3
18.8±0.2
8.3±0.3*
46.3±0.3
Diameter of inhibition zones (mm) including disc diameter of 6 mm.
Values are expressed as mean ± SEM.
5 µl of 5 mg/ml vancomycin.
5 µl of 50 mg/ml cycloserine.
10 µl of 50 mg/ml cefuroxime.
5 µl of 50 mg/ml isoniazid.
*, P<0.05 when compared to
mc2155/pSE100.
Diameter of inhibition zones (mm) including disc diameter of 6 mm.
Values are expressed as mean ± SEM.5 µl of 5 mg/ml vancomycin.5 µl of 50 mg/ml cycloserine.10 µl of 50 mg/ml cefuroxime.5 µl of 50 mg/ml isoniazid.*, P<0.05 when compared to
mc2155/pSE100.
Discussion
M. tuberculosis must adapt to harsh environmental conditions within
the host to successfully establish, maintain, or reactivate from acute and/or
chronic infection states. As one part of its survival strategy, the bacterium
encodes proteases and chaperones which act to either degrade and/or refold proteins
whose structure has become altered following stress exposure.
Mycobacteria encode homologs of the evolutionary conserved HtrA
family of proteins, which have been shown in both Gram-negative and Gram-positive
organisms to regulate adaptation to extracytoplasmic stress [26], [27], [28], [29]. In M.
tuberculosis, the physiological role of HtrA-family proteins has
remained largely undefined. Here, we provide further insight into one HtrA family
member, PepD, which has been previously shown to impact the MprAB and SigE stress
response networks in M. tuberculosis in vitro
[12], and
contribute to M. tuberculosis virulence in vivo
[11].While PepD is predicted to localize to the cell membrane in M.
tuberculosis, subcellular fractionation studies carried out with
M. tuberculosis and M. smegmatis expressing
wild-type or epitope-tagged forms of PepD indicate that this protein localizes to
multiple subcellular compartments, including the cell membrane, the cell wall, and
the CFP. Interestingly, mutations to the catalytic serine at position 317 of PepD
affect not only the ability of the protein to undergo autocatalysis [11], but
also affect its pattern of localization and its ability to be secreted into the CFP.
In contrast to wild-type PepD, PepDS317A is observed predominantly in the cell wall
with little protein observed in the cell membrane and culture filtrate. The size of
the PepD product secreted into the culture filtrate is consistent with the
∼35-kDa autoproteolytic peptide observed previously by LC-MALDI-MS and LC-ESI-MS
in vitro with purified protein [11]. While this peptide
presumably retains the catalytic and PDZ domains, it remains unclear whether this
peptide has a biological function once secreted. We were unable to detect by
immunoblot the 10-kDa autoproteolytic product previously reported by
MohamedMohaideen et al. to contain the PDZ domain alone [11]. It
is possible that this product may exhibit a short half-life, or may be further
processed into a form that is outside the detection parameters used in these
studies.In an effort to delineate the specific mechanism by which PepD contributes to the
M. tuberculosis stress response, a proteomic approach was used
to identify proteins or protein complexes that interact with PepD. In M.
tuberculosis or M. smegmatis, the most prominent PepD
binding protein identified was the 35-kDa antigen, Rv2744c or MSMEG_2695,
respectively. Bioinformatic analysis indicates that Rv2744c is a member of the PspA
family of proteins. These proteins participate in the phage shock response that has
been largely studied in Gram-negative bacteria where they are thought to participate
in multiple functions. In bacteria, PspA is involved in maintaining the proton
motive force [24],
and it acts as a negative regulator of the psp operon [30], [31]. A PspA homolog
in plants, VIPP1, is important in photosynthesis [32], [33]. In M.
tuberculosis, Rv2744c lies in an operon with upstream
transcription factor clgR and downstream gene
Rv2743c encoding a predicted membrane protein [2]. ClgR regulates
its own expression and several other genes in M. tuberculosis
including proteases and chaperones involved in protein homeostasis [34]. ClgR may
also regulate determinants involved in the maintenance of cellular redox potential
and energy generation [35]. clgR is upregulated in M.
tuberculosis following exposure to various extracytoplasmic stress
including subinhibitory concentrations of vancomycin and thioridazine [25], [36]. Vancomycin
interferes with peptidoglycan biosynthesis, and thioridazine is believed to inhibit
efflux pumps in M. tuberculosis leading to a disruption in aerobic
respiration [37],
[38].
clgR is also upregulated following redox stress, heat shock,
acid stress, and during intramacrophage growth [35]. Interestingly,
pepD and Rv2744c are both regulated by SigE,
suggesting these proteins may respond to similar stresses [39].While both PepD and the 35-kDa antigen localize to the cell membrane and cell wall,
the nature of their interaction remains unclear. Proteomic studies indicate that the
35-kDa antigen is a substrate for PepD proteolysis. A processed form of epitope
tagged Rv2744c is present in cell wall and cell membrane fractions prepared from
M. smegmatis ΔpepD strains expressing
M. tuberculosis pepD but not the catalytic site mutant,
pepDS317A (Figure
3D). Additionally, a protein corresponding to endogenous MSMEG_2695 is
co-immunoprecipitated from whole cell lysates prepared from M.
smegmatis ΔpepD strains expressing M.
tuberculosis pepDS317A but not wild-type M. tuberculosispepD (Figure 3A).
However, we have been unable to demonstrate proteolysis of purified Rv2744c by
PepDΔTM in vitro (data not shown). This could be due to a
number of factors. It is possible that proteolysis requires involvement of an
accessory protein or some other activating interaction, similar to what is seen with
other HtrA family members [14], [15], [40]. Consistent with this possibility, LC-MS/MS data indicate
that PepD potentially forms complexes with multiple proteins. Alternatively, it is
possible that PepDΔTM is not capable of binding purified epitope-tagged Rv2744c
or mediating its cleavage. Interestingly, Rv2744c seems to associate with a specific
isoform of PepD that is slightly smaller than that predicted for the full-length
protein (Figure 3B). Given that
PepDΔTM lacks the cytoplasmic domain and transmembrane domain, it may be unable
to assume the proper confirmation necessary for efficient Rv2744c interaction and/or
cleavage. While we predict that the PDZ domain of PepD mediates protein interactions
with the 35-kDa antigen, PepD also possesses a large cytoplasmic domain. A subset of
proteins co-immunoprecipitating with PepD in both M. tuberculosis
and M. smegmatis are predicted to localize to the cytoplasmic
compartment, raising the possibility that additional interactions may be mediated
through this domain. The HtrA-like protein Rv1223, which is predicted to be
essential in M. tuberculosis
[11],
[12], also
contains a large 175 amino acid cytoplasmic domain [2]; however, other HtrA-family
proteins in M. tuberculosis and in other organisms lack such a
domain. Therefore, further work is needed to delineate whether additional
interactions within the bacterial cell cytoplasm are necessary for optimal
autocatalysis or processing of substrates by PepD in the extracytoplasmic space.In addition to the 35-kDa antigen, three other proteins were identified as potential
substrates of PepD based on proteomic analyses. AtpD is an ATP synthase subunit
involved in maintaining the proton motive force in Gram-positive bacteria [41], [42]. DnaK is an
ubiquitous chaperone protein involved in the heat shock response [43], [44]. PknH is a
membrane-associated serine/threonine kinase involved in signal transduction, and is
necessary for arabinose metabolism [45]. The identified PepD cleavage site for PknH occurs near
the transmembrane domain on the cytoplasmic face, a location unlikely to be
accessible by the PepD protease domain. However, it is possible that PknH is cleaved
by two separate proteases at the transmembrane interface in a fashion similar to
RseB in E. coli. This process, termed Regulated Intramembrane
Proteolysis (RIP), involves the activities of an HtrA-family protease, DegS, and a
metalloprotease, RseP (YaeL) [26]. Because the extracytoplasmic side of the transmembrane
domain of PknH contains an arginine and lysine, it is conceivable that PepD cleaves
in this area and produces a peptide that was missed during our semi-tryptic mass
spectrometric analysis. Alternatively, the peptide identified may be the product of
a cleavage event mediated by another protease, as PepD was able to
co-immunoprecipitate multiple proteases in both M. tuberculosis and
M. smegmatis. Regardless, the identified binding proteins and
substrates provide a starting point for further investigations into the
physiological role of PepD in M. tuberculosis.Based on this data, we postulate that PepD functions to proteolytically regulate
Rv2744c levels to help maintain cell wall/cell envelope homeostasis in M.
tuberculosis (Figure
4). A model is also proposed that builds upon observations previously
reported by Barik et al
[46] and others
[3], [47], [48] concerning
interactions between the SigE and MprAB signalling pathways in M.
tuberculosis following exposure to extracytoplasmic stress. The
serine/threonine protein kinase, PknB, contains PASTA domains that have been
postulated to bind peptidoglycan and may serve as cell wall sensors [49]. As the
peptidoglycan becomes disordered due to extracellular stress, PknB activates and
phosphorylates RseA, the anti-sigma factor of SigE. Phosporylation of RseA leads to
proteolytic degradation of this protein by ClpC1P2, releasing SigE and inducing
expression of components of the SigE regulon including mprA and
clgR
[39], [46], [50]. MprA and ClgR in
turn upregulate gene products within their cognate regulons including
clgR itself, clpC1, clpP2,
ppk1, pepD, and sigE
[3], [34], [35]. Upregulation of
clp genes initiates a positive feedback loop through SigE by
enhancing degradation of RseA. Similarly, upregulation of ppk1
encoding polyphosphate kinase increases polyphosphate levels and enhances activation
of the MprAB two-component system [47], mediating a positive feedback loop through SigE [3]. The Rv2744c
generated following upregulation of clgR is secreted
extracytoplasmically, where it functions in an as-of-yet undefined role to help
mediate resistance to the recognized stress. In Escherichia coli
and other bacterial species, PspA forms higher order oligomers where the protein is
thought to function as a structural scaffold to help maintain proton motive force
[51], [52], [53], [54]. While it is
currently unclear if higher order oligomers are formed by Rv2744c in M.
tuberculosis, Rv2744c can interact with itself in bacterial two-hybrid
assays carried out in E. coli (Figure S2).
Over-production of Rv2744c and/or exposure of this protein to stress that perturbs
the cell wall, including that mediated through peptidoglycan-disrupting agents, may
lead to unstructured regions of Rv2744c that become recognized by PepD. Subsequent
processing by PepD would help minimize the over-accumulation of Rv2744c in the cell
wall/cell membrane. Alternatively, cleavage by PepD may be important for some aspect
of Rv2744c function. Finally, it is also possible that cleavage of Rv2744c by PepD
may represent a mechanism for terminating the membrane stress response following
cessation of the inducing stimulus. While none of these possibilities are mutually
exclusive, production of Rv2744c helps restore resistance of M.
smegmatis ΔpepD strains to
peptidoglycan-perturbing agents, allowing maintenance of cell wall homeostasis
following exposure to extracytoplasmic stress. Future studies are aimed at
delineating the specific mechanism by which Rv2744c participates in cell wall
homeostasis, and defining the other factors that participate in this stress response
pathway.
Figure 4
Model of Rv2744c regulation by PepD.
Under stress conditions that alter cell wall peptidoglycan, PknB becomes
activated and phosphorylates RseA. RseA phosphorylation leads to proteolytic
degradation by the ClpC1P2 protease, releasing sigma factor SigE and
activating gene determinants comprising the SigE regulon. SigE positively
regulates clgR, Rv2744c, and
mprA. ClgR autoregulates its own expression and that of
downstream gene Rv2744c, and upregulates expression of
other genes including ppk1, clpC1, and
clpC2. MprA in turn upregulates sigE
expression, leading to the direct and indirect upregulation of
pepD. Rv2744c traffics to the cell membrane and cell
wall where it may oligomerize and help maintain cell envelope homeostasis.
PepD traffics to the same cellular compartment where it acts to maintain
Rv2744c at appropriate levels. Cessation of peptidoglycan stress results in
RseA stabilization, sequestration of SigE, and subsequent downmodulation of
the SigE and MprA signaling pathways.
Model of Rv2744c regulation by PepD.
Under stress conditions that alter cell wall peptidoglycan, PknB becomes
activated and phosphorylates RseA. RseA phosphorylation leads to proteolytic
degradation by the ClpC1P2 protease, releasing sigma factor SigE and
activating gene determinants comprising the SigE regulon. SigE positively
regulates clgR, Rv2744c, and
mprA. ClgR autoregulates its own expression and that of
downstream gene Rv2744c, and upregulates expression of
other genes including ppk1, clpC1, and
clpC2. MprA in turn upregulates sigE
expression, leading to the direct and indirect upregulation of
pepD. Rv2744c traffics to the cell membrane and cell
wall where it may oligomerize and help maintain cell envelope homeostasis.
PepD traffics to the same cellular compartment where it acts to maintain
Rv2744c at appropriate levels. Cessation of peptidoglycan stress results in
RseA stabilization, sequestration of SigE, and subsequent downmodulation of
the SigE and MprA signaling pathways.Localization of 3xFLAG-PepD-6xHis in
. Western blot demonstrating
the localization of an overexpressed 3xFLAG-PepD-6xHis variant in M.
smegmatis mc2155. Lanes: CFP, culture filtrate
protein; CW, cell wall; CM, cell membrane; Cyt, cytosol.(TIF)Click here for additional data file.Quantification of Rv2744c interaction by bacterial two-hybrid
assays.
E. coli BTH101 was transformed with various bacterial
two-hybrid plasmids and subjected to β-galactosidase assays to quantify
protein-protein interactions. pKT25 and pUT18 without inserts served as the
negative control. pTZ1185 (pKT25 containing Rv2744c) and
pTZ1182 (pUT18 containing Rv2744c) were used to investigate
interaction of Rv2744c with itself. pKT25zip and pUT18Czip served as the
positive control.(TIF)Click here for additional data file.Bacterial strains and plasmids used in this study.(RTF)Click here for additional data file.Oligonucleotides used in this study.(RTF)Click here for additional data file.Proteins from M. smegmatis whole cell lysate
co-immunoprecipitating with 3xFLAG-PepDS317A-6xHis.(XLSX)Click here for additional data file.Proteins from M. smegmatis cell wall fraction
co-immunoprecipitating with 3xFLAG-PepDS317A-6xHis.(XLSX)Click here for additional data file.Proteins identified in both M. smegmatis cell wall and whole
cell lysate preparations that co-immunoprecipitate with
3x-FLAG-PepDS317A-6xHis.(RTF)Click here for additional data file.Proteins from M. tuberculosis whole cell lysate
co-immunoprecipitating with 3xFLAG-PepDS317A-6xHis.(XLSX)Click here for additional data file.PepD proteolysis of M. tuberculosis proteins
co-immunoprecipitating with 3xFLAG-PepDS317A-6xHis.(XLSX)Click here for additional data file.Identification of putative autolytic PepD cleavage sites using LC-MS/MS.(RTF)Click here for additional data file.
Authors: Rebecca L Wilson; Lindsay L Brown; Dana Kirkwood-Watts; Travis K Warren; S Amanda Lund; David S King; Kevin F Jones; Dennis E Hruby Journal: Infect Immun Date: 2006-01 Impact factor: 3.441
Authors: Kerstin Standar; Denise Mehner; Hendrik Osadnik; Felix Berthelmann; Gerd Hause; Heinrich Lünsdorf; Thomas Brüser Journal: FEBS Lett Date: 2008-10-10 Impact factor: 4.124
Authors: Megan Estorninho; Hilde Smith; Jelle Thole; Jose Harders-Westerveen; Andrzej Kierzek; Rachel E Butler; Olivier Neyrolles; Graham R Stewart Journal: Microbiology Date: 2010-08-05 Impact factor: 2.777
Authors: S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell Journal: Nature Date: 1998-06-11 Impact factor: 49.962
Authors: Petros C Karakousis; Tetsuyuki Yoshimatsu; Gyanu Lamichhane; Samuel C Woolwine; Eric L Nuermberger; Jacques Grosset; William R Bishai Journal: J Exp Med Date: 2004-09-06 Impact factor: 14.307
Authors: Marina A Forrellad; Laura I Klepp; Andrea Gioffré; Julia Sabio y García; Hector R Morbidoni; María de la Paz Santangelo; Angel A Cataldi; Fabiana Bigi Journal: Virulence Date: 2012-10-17 Impact factor: 5.882
Authors: Pratik Datta; Janani Ravi; Valentina Guerrini; Rinki Chauhan; Matthew B Neiditch; Scarlet S Shell; Sarah M Fortune; Baris Hancioglu; Oleg A Igoshin; Maria Laura Gennaro Journal: Mol Microbiol Date: 2015-05-26 Impact factor: 3.501
Authors: Daniel J Bretl; Hongjun He; Crystalla Demetriadou; Mark J White; Renee M Penoske; Nita H Salzman; Thomas C Zahrt Journal: Infect Immun Date: 2012-06-11 Impact factor: 3.441
Authors: Richard M Armstrong; Dominique C Carter; Samantha N Atkinson; Scott S Terhune; Thomas C Zahrt Journal: J Bacteriol Date: 2018-07-25 Impact factor: 3.490
Authors: Richard M Armstrong; Katherine L Adams; Joseph E Zilisch; Daniel J Bretl; Hiromi Sato; David M Anderson; Thomas C Zahrt Journal: J Bacteriol Date: 2016-05-13 Impact factor: 3.490